• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

作者信息

Dreyling M, Ghielmini M, Rule S, Salles G, Ladetto M, Tonino S H, Herfarth K, Seymour J F, Jerkeman M

机构信息

Department of Medicine III, LMU Hospital Munich, Germany.

Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.

出版信息

Ann Oncol. 2021 Mar;32(3):298-308. doi: 10.1016/j.annonc.2020.11.008. Epub 2020 Nov 26.

DOI:10.1016/j.annonc.2020.11.008
PMID:33249059
Abstract
摘要

相似文献

1
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Mar;32(3):298-308. doi: 10.1016/j.annonc.2020.11.008. Epub 2020 Nov 26.
2
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2014 Sep;25 Suppl 3:iii76-82. doi: 10.1093/annonc/mdu200. Epub 2014 Aug 13.
3
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v83-v90. doi: 10.1093/annonc/mdw400.
4
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma.欧洲肿瘤内科学会（ESMO）关于新诊断滤泡性淋巴瘤诊断、治疗及随访的最低临床建议
Ann Oncol. 2003 Aug;14(8):1163-4. doi: 10.1093/annonc/mdg338.
5
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发的滤泡性淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2010 May;21 Suppl 5:v181-3. doi: 10.1093/annonc/mdq184.
6
Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii77-8. doi: 10.1093/annonc/mdn096.
7
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发的滤泡性淋巴瘤：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2011 Sep;22 Suppl 6:vi59-63. doi: 10.1093/annonc/mdr388.
8
Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2009 May;20 Suppl 4:119-20. doi: 10.1093/annonc/mdp148.
9
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发的套细胞淋巴瘤：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2014 Sep;25 Suppl 3:iii83-92. doi: 10.1093/annonc/mdu264.
10
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials.idelalisib、来那度胺和利妥昔单抗在复发难治性淋巴瘤中的安全性和耐受性：肿瘤临床试验联盟A051201和A051202 1期试验
Lancet Haematol. 2017 Apr;4(4):e176-e182. doi: 10.1016/S2352-3026(17)30028-5. Epub 2017 Mar 15.

引用本文的文献

1
Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study.EZH2抑制剂他泽司他在中国复发/难治性滤泡性淋巴瘤患者中的疗效和安全性：一项多中心、单臂、2期研究。
EClinicalMedicine. 2025 Aug 18;87:103399. doi: 10.1016/j.eclinm.2025.103399. eCollection 2025 Sep.
2
Recent advances in phototherapy-based nanomedicine of lymphoma.基于光疗法的淋巴瘤纳米医学的最新进展。
Mater Today Bio. 2025 Jul 3;33:102047. doi: 10.1016/j.mtbio.2025.102047. eCollection 2025 Aug.
3
Rethinking bone marrow biopsy: is PET/CT enough for staging low-grade follicular lymphomas?
重新审视骨髓活检：PET/CT对于低度滤泡性淋巴瘤分期是否足够？
Ann Hematol. 2025 Jul 17. doi: 10.1007/s00277-025-06487-8.
4
Long-acting lipegfilgrastim and antimicrobials as vigorous primary prophylaxis in bendamustine-treated patients with indolent B cell non-Hodgkin lymphoma: a multicentric real-life experience.长效聚乙二醇非格司亭与抗菌药物作为苯达莫司汀治疗的惰性B细胞非霍奇金淋巴瘤患者的强效一级预防：一项多中心真实世界经验
Support Care Cancer. 2025 Jul 14;33(8):691. doi: 10.1007/s00520-025-09743-9.
5
Two Cases of Small Intestinal Follicular Lymphoma Presenting with Intestinal Stricture.两例表现为肠道狭窄的小肠滤泡性淋巴瘤
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.25-0108. Epub 2025 Jun 18.
6
Incidental Finding of a Primary Polypoid Low-Grade B-Cell Gastric Lymphoma Managed with Chemotherapy.偶然发现的原发性息肉样低级别B细胞胃淋巴瘤，采用化疗进行治疗。
Am J Case Rep. 2025 Jun 20;26:e947782. doi: 10.12659/AJCR.947782.
7
Follicular Lymphoma: Current Therapeutic Landscape and Future Prospects.滤泡性淋巴瘤：当前的治疗格局与未来前景
Hematol Oncol. 2025 Jun;43 Suppl 2(Suppl 2):e70070. doi: 10.1002/hon.70070.
8
Real-world treatment patterns and clinical outcomes in patients with follicular lymphoma: a SEER-Medicare analysis.滤泡性淋巴瘤患者的真实世界治疗模式与临床结局：一项监测、流行病学和最终结果数据库（SEER）与医疗保险数据分析
Blood Neoplasia. 2025 Feb 21;2(2):100080. doi: 10.1016/j.bneo.2025.100080. eCollection 2025 May.
9
Efficacy and safety of rituximab biosimilar (DRL_RI) versus MabThera in low-tumor-burden follicular lymphoma: the FLINTER study.利妥昔单抗生物类似药（DRL_RI）与美罗华治疗低肿瘤负荷滤泡性淋巴瘤的疗效和安全性：FLINTER研究
Ther Adv Med Oncol. 2025 May 24;17:17588359251339925. doi: 10.1177/17588359251339925. eCollection 2025.
10
Integration of gene mutations in risk prognostication for watch-and-wait follicular lymphoma patients initiating first-line treatment.基因变异在初治观察等待型滤泡性淋巴瘤患者风险预后评估中的整合
Hemasphere. 2025 May 7;9(5):e70141. doi: 10.1002/hem3.70141. eCollection 2025 May.